Guangdong Marubi Biotechnology Past Earnings Performance
Past criteria checks 3/6
Guangdong Marubi Biotechnology's earnings have been declining at an average annual rate of -19.5%, while the Personal Products industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 7.3% per year. Guangdong Marubi Biotechnology's return on equity is 10%, and it has net margins of 12.3%.
Key information
-19.5%
Earnings growth rate
-20.7%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | 7.3% |
| Return on equity | 10.0% |
| Net Margin | 12.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30
Recent updates
Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?
Nov 22Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher
Sep 26Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Revenue & Expenses Breakdown
How Guangdong Marubi Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,641 | 324 | 1,581 | 72 |
| 30 Jun 24 | 2,518 | 305 | 1,510 | 69 |
| 31 Mar 24 | 2,410 | 291 | 1,439 | 65 |
| 31 Dec 23 | 2,226 | 259 | 1,305 | 62 |
| 30 Sep 23 | 2,124 | 228 | 1,213 | 60 |
| 30 Jun 23 | 1,974 | 188 | 1,107 | 57 |
| 31 Mar 23 | 1,826 | 187 | 1,015 | 53 |
| 31 Dec 22 | 1,732 | 174 | 960 | 53 |
| 30 Sep 22 | 1,793 | 226 | 903 | 49 |
| 30 Jun 22 | 1,730 | 176 | 897 | 51 |
| 31 Mar 22 | 1,766 | 213 | 872 | 52 |
| 31 Dec 21 | 1,787 | 248 | 842 | 50 |
| 30 Sep 21 | 1,745 | 268 | 765 | 53 |
| 30 Jun 21 | 1,825 | 385 | 730 | 51 |
| 31 Mar 21 | 1,779 | 446 | 680 | 52 |
| 31 Dec 20 | 1,745 | 464 | 643 | 50 |
| 30 Sep 20 | 1,727 | 494 | 633 | 52 |
| 30 Jun 20 | 1,780 | 527 | 627 | 51 |
| 31 Mar 20 | 1,806 | 514 | 643 | 46 |
| 31 Dec 19 | 1,801 | 515 | 631 | 45 |
| 30 Sep 19 | 1,732 | 539 | 614 | 37 |
| 30 Jun 19 | 1,662 | 477 | 627 | 35 |
| 31 Mar 19 | 1,606 | 440 | 605 | 34 |
| 31 Dec 18 | 1,576 | 415 | 606 | 34 |
| 31 Dec 17 | 1,352 | 312 | 536 | 28 |
| 31 Dec 16 | 1,208 | 232 | 530 | 25 |
Quality Earnings: 603983 has a large one-off gain of CN¥86.3M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 603983's current net profit margins (12.3%) are higher than last year (10.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603983's earnings have declined by 19.5% per year over the past 5 years.
Accelerating Growth: 603983's earnings growth over the past year (42.3%) exceeds its 5-year average (-19.5% per year).
Earnings vs Industry: 603983 earnings growth over the past year (42.3%) exceeded the Personal Products industry -6%.
Return on Equity
High ROE: 603983's Return on Equity (10%) is considered low.